Abstract
The increasing use of buprenorphine among drug dependent subjects demands systematic enquiry into the clinical profile of buprenorphine withdrawal. Six male buprenorphine dependent (parenteral) subjects were observed for opiate withdrawal over a two week period. The onset of withdrawal occurred 48 hours after the last dose, peaked around the third day and lasted up to ten days. The withdrawals were similar to morpliine type drugs and moderate in intensity.
Keywords: buprenorphine, morpliine, opiate withdrawal
Full Text
The Full Text of this article is available as a PDF (114.0 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bickel W. K., Stitzer M. L., Bigelow G. E., Liebson I. A., Jasinski D. R., Johnson R. E. A clinical trial of buprenorphine: comparison with methadone in the detoxification of heroin addicts. Clin Pharmacol Ther. 1988 Jan;43(1):72–78. doi: 10.1038/clpt.1988.13. [DOI] [PubMed] [Google Scholar]
- Fudala P. J., Jaffe J. H., Dax E. M., Johnson R. E. Use of buprenorphine in the treatment of opioid addiction. II. Physiologic and behavioral effects of daily and alternate-day administration and abrupt withdrawal. Clin Pharmacol Ther. 1990 Apr;47(4):525–534. doi: 10.1038/clpt.1990.67. [DOI] [PubMed] [Google Scholar]
- Handelsman L., Cochrane K. J., Aronson M. J., Ness R., Rubinstein K. J., Kanof P. D. Two new rating scales for opiate withdrawal. Am J Drug Alcohol Abuse. 1987;13(3):293–308. doi: 10.3109/00952998709001515. [DOI] [PubMed] [Google Scholar]
- Jasinski D. R., Pevnick J. S., Griffith J. D. Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction. Arch Gen Psychiatry. 1978 Apr;35(4):501–516. doi: 10.1001/archpsyc.1978.01770280111012. [DOI] [PubMed] [Google Scholar]
- Kosten T. R., Kleber H. D., Morgan C. Role of opioid antagonists in treating intravenous cocaine abuse. Life Sci. 1989;44(13):887–892. doi: 10.1016/0024-3205(89)90589-4. [DOI] [PubMed] [Google Scholar]
- Kosten T. R., Krystal J. H., Charney D. S., Price L. H., Morgan C. H., Kleber H. D. Opioid antagonist challenges in buprenorphine maintained patients. Drug Alcohol Depend. 1990 Feb;25(1):73–78. doi: 10.1016/0376-8716(90)90144-4. [DOI] [PubMed] [Google Scholar]
- O'Connor J. J., Moloney E., Travers R., Campbell A. Buprenorphine abuse among opiate addicts. Br J Addict. 1988 Sep;83(9):1085–1087. doi: 10.1111/j.1360-0443.1988.tb00536.x. [DOI] [PubMed] [Google Scholar]
- Quigley A. J., Bredemeyer D. E., Seow S. S. A case of buprenorphine abuse. Med J Aust. 1984 Mar 31;140(7):425–426. doi: 10.5694/j.1326-5377.1984.tb108106.x. [DOI] [PubMed] [Google Scholar]
- Reisinger M. Buprenorphine as new treatment for heroin dependence. Drug Alcohol Depend. 1985 Dec;16(3):257–262. doi: 10.1016/0376-8716(85)90050-x. [DOI] [PubMed] [Google Scholar]
- San L., Camí J., Fernández T., Ollé J. M., Peri J. M., Torrens M. Assessment and management of opioid withdrawal symptoms in buprenorphine-dependent subjects. Br J Addict. 1992 Jan;87(1):55–62. doi: 10.1111/j.1360-0443.1992.tb01900.x. [DOI] [PubMed] [Google Scholar]
- Seow S. S., Quigley A. J., Ilett K. F., Dusci L. J., Swensen G., Harrison-Stewart A., Rappeport L. Buprenorphine: a new maintenance opiate? Med J Aust. 1986 Apr 14;144(8):407–411. doi: 10.5694/j.1326-5377.1986.tb128412.x. [DOI] [PubMed] [Google Scholar]